Overview

Efficacy and Safety of Darunavir and Cobicistat for Treatment of COVID-19

Status:
Recruiting
Trial end date:
2020-12-31
Target enrollment:
Participant gender:
Summary
The study aims to evaluate the efficacy and safety of darunavir and cobistastat in the treatment of COVID-19 pneumonia
Phase:
Phase 3
Details
Lead Sponsor:
Shanghai Public Health Clinical Center
Treatments:
Cobicistat
Darunavir